SCHEMBL24330852

SCHEMBL24330852

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5nc6ccccc6c6cc7c(cc56)-c5ccccc5C75c6ccccc6Sc6ccccc65)cc4)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
ATM Q13315 2/20 0.43
WHR1 P49842 1/20 0.33
DHODH Q02127 2/20 0.32
MAPT P10636 2/20 0.32
NUDT1 P36639 2/20 0.32
GAA P10253 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.31
ADORA2A P29274 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
THRB P10828 1/20 0.31
PDE5A O76074 1/20 0.30
TLR9 Q9NR96 1/20 0.30
KDM1A O60341 1/20 0.30
CSNK2A2 P19784 1/20 0.30
CSNK2B P67870 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24330967 1.00 KMT2A (0.43) KMT2AMEN1ATMWHR1DHODH
SCHEMBL24330908 0.99 KMT2A (0.43) KMT2AMEN1ATMWHR1DHODH
SCHEMBL24330971 0.99 KMT2A (0.43) KMT2AMEN1ATMWHR1DHODH
SCHEMBL24330863 0.96 MEN1 (0.40) KMT2AMEN1ATMWHR1
SCHEMBL24330854 0.96 MEN1 (0.40) KMT2AMEN1ATMWHR1
SCHEMBL24330664 0.96 MEN1 (0.46) KMT2AMEN1ATMWHR1DHODH
SCHEMBL24330640 0.95 MEN1 (0.38) KMT2AMEN1ATMWHR1DHODH
SCHEMBL24330877 0.95 MEN1 (0.38) KMT2AMEN1ATMABCG2
SCHEMBL24331871 0.95 MEN1 (0.38) KMT2AMEN1ATMWHR1DHODH
SCHEMBL22017553 0.95 MEN1 (0.38) KMT2AMEN1ATMWHR1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220123225-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220123225-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 KMT2A 794/4885MEN1 343/4885ATM 3263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.